28 July, 2005  23:10 GMT
 Senate bill calls for restriction of cold medicine sales.
Sales of cold medicines used to make methamphetamine would be restricted under a bill that cleared the Senate Judiciary Committee Thursday after lawmakers forged a compromise protecting state prerogatives.
The legislation would require stores to sell Sudafed, Nyquil and other
medicines containing pseudoephedrine only from behind the pharmacy counter. In
makeshift labs across the country, the ingredient has been extracted and used to
cook meth.
Prevent Customers from Exceeding Limits
Consumers would have to show a
photo ID, sign a log, and be limited to 7.5 grams -- or about 250
30-milligram pills -- in a 30-day period. Computer tracking would prevent customers from
exceeding the limit at other stores, according to the bipartisan bill
co-sponsored by Sens. Dianne Feinstein, D-Calif., and Jim Talent, R-Mo.
Authorities said Thursday that Walgreen Co. agreed to pay $1.3 million to
settle claims that it broke state and federal laws by failing to monitor sales
of over-the-counter cold medicine that can be used to make methamphetamine. The
company also agreed to spend $1 million to monitor purchases of the medicine. It
did not admit to any wrongdoing.
Concerns Over States' Rights
The Feinstein-Talent measure had been
stalled in committee for several weeks over concerns that it could stop states
from enacting their own rules on cold medicine sales. It was modeled after an
Oklahoma law that took effect last year, and Sen. Tom Coburn, R-Okla.,
complained it could interfere with his state's rules.
The bill was approved by voice vote after lawmakers accepted an amendment by
Coburn that would allow states to adopt and enforce their own rules, as long as
they are at least as strict as those set out in the federal law.
Another
amendment, by Sen. Orrin Hatch, R-Utah, would delay the implementation date of
the legislation until Jan. 1, 2007, for products containing pseudoephedrine in
combination with other ingredients. For products in which pseudoephedrine is the
only active ingredient, the restrictions would take effect 90 days after
enactment.
"Today is a good day in the fight against methamphetamine. We're one step
closer to enacting a national meth bill that would put thousands of meth labs
out of business," Feinstein said.
But Coburn's amendment could renew resistance from retailers who don't want
to deal with a patchwork of state regulations on cold medicine sales.
A Series of Compromises
"We made the strong argument that if you
wanted retailers to enforce this law across the country with vigor and with
correctness, you needed to have a national standard so we didn't have to train
all of our employees differently," said John Motley, senior vice president of
government and public affairs for the Food Marketing Institute, which represents
grocery stores and other retailers.
After initial opposition to the bill, retailers had been won over with a
series of compromises, including an exception for stores without a pharmacist on
duty, such as convenience stores and some grocery chains. That exception allowed
states to work with the Drug Enforcement Administration to license certain
employees who are not pharmacists to sell the medicines.
The bill also contains an airport exemption that would allow sales of single
packages of cold medicine by stores inside airports.
In addition, Coburn's amendment says states can choose to allow
over-the-counter sales of children's cold medicine containing 15 milligrams or
less of pseudoephedrine, something Coburn believed was needed so parents could
respond quickly to children's illnesses.
Coburn said he thought most retailers would eventually come on board.
"A little bit of discomfort for the retailers isn't going to hurt them,
because the goal ultimately is to help people," he said.
Talent and Feinstein said they hoped to get the bill passed by the full
Senate in September. A similar measure has been introduced in the House by Rep.
Roy Blunt, R-Mo.

 |